The role of a multidisciplinary heart failure clinic in optimization of guideline-directed medical therapy: HF-optimize

被引:6
|
作者
Diederich, Theresa [1 ]
Burdorf, Adam [2 ]
Pozehl, Bunny [3 ]
Bowman, Stephanie [4 ]
Ferguson, Kelly [1 ]
Holder, Kyana [1 ]
Alonso, Windy [3 ]
Stoller, Douglas [2 ]
Lundgren, Scott [2 ]
机构
[1] Nebraska Med, Cardiol, Omaha, NE USA
[2] Univ Nebraska Med Ctr, Cardiol, Omaha, NE USA
[3] Univ Nebraska Med Ctr, Coll Nursing, Omaha, NE USA
[4] Nebraska Med, Pharm, Omaha, NE USA
来源
HEART & LUNG | 2023年 / 57卷
关键词
Multidisciplinary heart failure clinic; Guideline-directed medical therapy; Heart failure outcomes; Health related quality of life; 2013 ACCF/AHA GUIDELINE; ASSOCIATION TASK-FORCE; AMERICAN-COLLEGE; MANAGEMENT;
D O I
10.1016/j.hrtlng.2022.08.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Guideline-directed medical therapy (GDMT) reduces mortality and hospitalizations in adults with heart failure with reduced ejection fraction (HFrEF); however, few are receiving GDMT. National registries show as few as 1% of patients are receiving appropriate GDMT. Development of heart failure clinics achieving optimal GDMT are crucial to improve outcomes for HFrEF patients. Objective: We developed a multidisciplinary HF-Optimize clinic aimed at improving GDMT use along with providing education, resources, and comorbidity screening for adults with HFrEF. Methods: We targeted patients with newly diagnosed HFrEF and/or recent or multiple admissions for 6 visits over 12 weeks. We measured medication use, ejection fraction, 6-minute walk test distance, and health-related quality of life (EuroQol Visual Analog Scale) at visits 1 and 6. Results: One-hundred ten patients completed all visits. Patients were a mean age of 58 (+14) years, 37% were female, and 42% were of non-White race. From visit 1 to visit 6, utilization of GDMT increased from 35.5% to 85.5% (p < 0.001) and significant improvements in ejection fraction (25.9% to 35.5%, p < 0.001), 6-minute walk distance (1032 feet to 1121.7 feet, p = 0.001), and quality of life (63.8/100 vs 70.8/100, p = 0.002). Only 2 patients (1.8%) that completed HF-Optimize had a 30-day heart failure readmission. Conclusion: Our multidisciplinary HF-Optimize clinic improved medication usage and clinical outcomes. Further studies are needed to validate outcomes of multidisciplinary GDMT clinics. (C) 2022 Elsevier Inc. All rights reserved.
引用
收藏
页码:95 / 101
页数:7
相关论文
共 50 条
  • [31] Interventions for Optimization of Guideline-Directed Medical Therapy
    Tang, Amber B.
    Brownell, Nicholas K.
    Roberts, Jacob S.
    Haidar, Amier
    Osuna-Garcia, Antonia
    Cho, David J.
    Bokhoor, Pooya
    Fonarow, Gregg C.
    JAMA CARDIOLOGY, 2024, 9 (04) : 397 - 404
  • [32] Remote Optimization of Guideline-Directed Medical Therapy in Patients With Heart Failure With Reduced Ejection Fraction
    Desai, Akshay S.
    Maclean, Taylor
    Blood, Alexander J.
    Bosque-Hamilton, Joshua
    Dunning, Jacqueline
    Fischer, Christina
    Fera, Liliana
    Smith, Katelyn V.
    Wagholikar, Kavishwar
    Zelle, David
    Gaziano, Thomas
    Plutzky, Jorge
    Scirica, Benjamin
    MacRae, Calum A.
    JAMA CARDIOLOGY, 2020, 5 (12) : 1430 - 1434
  • [33] Pharmacist-led Guideline-directed Medical Therapy (GDMT) Clinic For The Optimization Of Medications For Heart Failure With Reduced Ejection Fraction
    Twydell, Beth
    Kelsh, Shelby
    Dickinson, Michael
    Fermin, David
    Gonzalez, Matthew
    Grayburn, Ryan
    Jani, Milena
    Loyaga-rendon, Renzo
    Thorne, Anne
    Devries, Marilyn
    Lee, Sangjin
    JOURNAL OF CARDIAC FAILURE, 2025, 31 (01)
  • [34] Multimorbidity And Guideline-Directed Medical Therapy Intensification In Heart Failure: Findings From The EPIC-HF Trial
    Lipsey, Jonathan E.
    Mcilvennan, Colleen K.
    Helmkamp, Laura J.
    Harger, Geoffrey
    Matlock, Daniel D.
    Allen, Larry A.
    JOURNAL OF CARDIAC FAILURE, 2022, 28 (05) : S13 - S13
  • [35] Guideline-directed medical therapy patterns in heart failure with reduced ejection fraction: the OPTIMA-HF registry
    Paolillo, S.
    Basile, C.
    Marzano, F.
    Di Santo, M.
    Galasso, G.
    Ameri, P.
    Nodari, S.
    Santoro, G.
    Severino, P.
    Guerra, F.
    Grigioni, F.
    Carluccio, E.
    Lillo, A.
    Senni, M.
    Perrone-Filardi, P.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [36] Guideline-Directed Medical Therapy After Hospitalization for Acute Heart Failure: Insights From the CONNECT-HF
    Shoji, Satoshi
    Kaltenbach, Lisa
    Granger, Bradi B.
    Fonarow, Gregg C.
    Al-Khalidi, Hussein R.
    Albert, Nancy M.
    Butler, Javed
    Allen, Larry A.
    Lanfear, David E.
    Thibodeau, Jennifer T.
    Chapman, Brittany M.
    Oliver-McNeil, Sandra M.
    Felker, G. Michael
    Pina, Ileana L.
    Granger, Christopher B.
    Hernandez, Adrian F.
    Devore, Adam D.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2024, 13 (24):
  • [37] Identifying Predictors of Timing to Guideline-Directed Medical Therapy for Medical Beneficiaries With Heart Failure
    Chiang, Melody
    Kim, Dennie
    Cascino, Thomas
    Hou, Hechuan
    Hawkins, Robert
    Funk, Kylee
    Aaronson, Keith D.
    Cabrera, Lourdes
    Likosky, Donald S.
    McCullough, Jeffrey
    CIRCULATION, 2023, 148
  • [38] Guideline-Directed Medical Therapy in Heart Failure The Treatment Is Not Worse Than the Disease
    Ambardekar, Amrut, V
    El Rafei, Abdelghani
    JACC-HEART FAILURE, 2023, 11 (04) : 437 - 439
  • [39] Diversity in heart failure management: Quo Vadis, guideline-directed medical therapy?
    Meguro, Tomomi
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2024, 415
  • [40] Impact of Intensive Guideline-Directed Medical Therapy for Ischemic Heart Failure Outcomes
    Crosier, Rebecca
    Freitas, Cassandra
    Ross, Heather J.
    Lawler, Patrick R.
    Austin, Peter C.
    Ko, Dennis T.
    Stukel, Therese A.
    Farkouh, Michael E.
    Wang, Xuesong
    Spertus, John A.
    Lee, Douglas S.
    CIRCULATION, 2019, 140